Atlas Trials

Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients

Clinical trial NCT03250572 · COMPLETED

Trial details

NCT number
NCT03250572
Sponsor
Ain Shams University
Status
COMPLETED
Study type
OBSERVATIONAL
Non-Alcoholic Fatty Liver Disease
Start date
2015-06-01
Primary completion
2016-07-01
Enrollment
113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.